Full Year 2024 Arecor Therapeutics PLC Earnings Call Transcript - Thomson StreetEvents

Full Year 2024 Arecor Therapeutics PLC Earnings Call Transcript

Full Year 2024 Arecor Therapeutics PLC Earnings Call Transcript - Thomson StreetEvents
Full Year 2024 Arecor Therapeutics PLC Earnings Call Transcript
Published Apr 22, 2025
10 pages (6630 words) — Published Apr 22, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of AREC.L earnings conference call or presentation 22-Apr-25 12:00pm GMT

  
Brief Excerpt:

...Particularly after a long bank holiday weekend, so as my name's Doctor Sarah Howell, and I'm the CEO of Arecor Therapeutics, and delighted to be joined today by David Ellam. So many of you will know that David joined us as interim CFO back in November of last year and very pleased to be able to confirm that he's now joined us permanently and of course, David will be talking us through the financials later in the presentation today. So we'll be talking through the results for Arecor Therapeutics for the year ending December 31, 2024. So our customary legal notice, of course. So just to give a very high level, I know certainly everybody in the room today knows the company very well by now, but Arecor are very much focused on transforming patient care by bringing enhanced therapeutics to market that reduce patient burden whilst improving outcomes. We do this by leveraging our innovative and proprietary formulation. Technology platform Arestat to develop novel formulations of existing therapeutics...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Arecor Therapeutics PLC
Ticker
AREC.L
Time
12:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Karl Keegan - Singer Capital Markets - Analyst : On those sheets that you showed there's quite -- oh, sorry. Yeah, so Karl Keegan, Singers. On the deal sheets, you showed that there was quite a lot of money going into like series A for platforms and how do you see the Arestat that platform sort of technically comparing or have you done that analysis to see or do you have a a a view that you can sort of allude to about where you might see some differentiation? And then secondly on from that, I mean, GLP-1 is a nice to have, but the other peptides, I mean, that really is the sort of the one that we haven't factored in to our analysis as yet, correct?

Question: Karl Keegan - Singer Capital Markets - Analyst : What was the potential -- ?

Table Of Contents

Full Year 2024 Arecor Therapeutics PLC Earnings Presentation (Shareholder Q&A) Transcript – 2025-05-01 – US$ 106.00 – Edited Transcript of AREC.L earnings conference call or presentation 1-May-25 1:00pm GMT

Arecor Therapeutics PLC to Announce Orderly Cessastion of Tetris Pharma and Mutual Agreement with Xeris Presentation Transcript – 2025-01-10 – US$ 54.00 – Edited Transcript of AREC.L conference call or presentation 10-Jan-25 8:45am GMT

Half Year 2024 Arecor Therapeutics PLC Earnings Presentation Transcript – 2024-09-26 – US$ 54.00 – Edited Transcript of AREC.L earnings conference call or presentation 26-Sep-24 8:30am GMT

Half Year 2023 Arecor Therapeutics PLC Earnings Presentation (Q&A) Transcript – 2023-09-20 – US$ 54.00 – Edited Transcript of AREC.L earnings conference call or presentation 20-Sep-23 1:00pm GMT

Half Year 2023 Arecor Therapeutics PLC Earnings Call Transcript – 2023-09-14 – US$ 54.00 – Edited Transcript of AREC.L earnings conference call or presentation 14-Sep-23 10:00am GMT

Full Year 2023 Arecor Therapeutics PLC Earnings Presentation (Q&A Session) Transcript – 2023-04-26 – US$ 54.00 – Edited Transcript of AREC.L earnings conference call or presentation 26-Apr-23 1:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Full Year 2024 Arecor Therapeutics PLC Earnings Call Transcript" Apr 22, 2025. Alacra Store. May 12, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Full-Year-2024-Arecor-Therapeutics-PLC-Earnings-Call-T16319609>
  
APA:
Thomson StreetEvents. (2025). Full Year 2024 Arecor Therapeutics PLC Earnings Call Transcript Apr 22, 2025. New York, NY: Alacra Store. Retrieved May 12, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Full-Year-2024-Arecor-Therapeutics-PLC-Earnings-Call-T16319609>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.